These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17571089)

  • 21. Coding for the use of botulinum toxin for movement disorders.
    Brashear A; Bushong L
    Continuum (Minneap Minn); 2013 Oct; 19(5 Movement Disorders):1406-15. PubMed ID: 24092297
    [No Abstract]   [Full Text] [Related]  

  • 22. Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion.
    Lim EC; Seet RC
    Acta Neurol Scand; 2008 Feb; 117(2):73-84. PubMed ID: 17850405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anhidrotic effect of intradermal injections of botulinum toxin: a comparison of different products and concentrations.
    Rystedt A; Swartling C; Naver H
    Acta Derm Venereol; 2008; 88(3):229-33. PubMed ID: 18480920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin A-induced protective ptosis in corneal disease.
    Kirkness CM; Adams GG; Dilly PN; Lee JP
    Ophthalmology; 1988 Apr; 95(4):473-80. PubMed ID: 3050691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Botulinum toxin useful against writer's cramp].
    Kruisdijk JJ; Koelman JH; Ongerboer de Visser BW; de Haan RJ; Speelman JD
    Ned Tijdschr Geneeskd; 2009 Jan; 153(4):118-23. PubMed ID: 19348131
    [No Abstract]   [Full Text] [Related]  

  • 26. Needle EMG guidance for injection of botulinum toxin. Needle EMG guidance is useful.
    Barbano RL
    Muscle Nerve; 2001 Nov; 24(11):1567-8. PubMed ID: 11745963
    [No Abstract]   [Full Text] [Related]  

  • 27. Needle EMG guidance for injection of botulinum toxin. Needle EMG guidance is rarely required.
    Jankovic J
    Muscle Nerve; 2001 Nov; 24(11):1568-70. PubMed ID: 11745964
    [No Abstract]   [Full Text] [Related]  

  • 28. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
    Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin follow-up clinics: training implications.
    Larner A
    J R Coll Physicians Lond; 2000; 34(2):217. PubMed ID: 10816888
    [No Abstract]   [Full Text] [Related]  

  • 30. Botulinum toxin treatment in patients with facial synkinesis.
    Laskawi R; Damenz W; Roggenkämper P; Baetz A
    Eur Arch Otorhinolaryngol; 1994 Dec; ():S195-9. PubMed ID: 10774349
    [No Abstract]   [Full Text] [Related]  

  • 31. [Botulinum toxin in headache].
    Simon O; Raibaut P; Faucher M; Sheik-Ismael S; Amarenco G
    Ann Readapt Med Phys; 2003 Jul; 46(6):312-8. PubMed ID: 12928136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeat injections of intra-articular botulinum toxin a for the treatment of chronic arthritis joint pain.
    Singh JA; Mahowald ML; Kushnaryov A; Goelz E; Dykstra D
    J Clin Rheumatol; 2009 Feb; 15(1):35-8. PubMed ID: 19131763
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of botulinum toxin injection for achalasia in Thai patients.
    Leelakusolvong S; Sinpeng T; Pongprasobchai S; Tanwandee T; Kachintorn U; Manatsathit S
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S67-72. PubMed ID: 17718248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of apraclonidine eyedrops to treat ptosis after the administration of botulinum toxin to the upper face.
    Scheinfeld N
    Dermatol Online J; 2005 Mar; 11(1):9. PubMed ID: 15748550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re: "thyroid eye disease presenting after cosmetic botulinum toxin injections".
    Baldeschi L; Lupetti A; Wiersinga WM
    Ophthalmic Plast Reconstr Surg; 2007; 23(6):498-9; author reply 499. PubMed ID: 18030134
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.
    Alrefai AH; Aburahma SK; Khader YS
    Clin Neurol Neurosurg; 2009 Jan; 111(1):79-82. PubMed ID: 18977585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further progress in understanding the pathophysiology of primary dystonia.
    Abbruzzese G; Berardelli A
    Mov Disord; 2011 Jun; 26(7):1185-6. PubMed ID: 21469213
    [No Abstract]   [Full Text] [Related]  

  • 38. Botulinum toxin in painful tardive dyskinesia.
    Tschopp L; Salazar Z; Micheli F
    Clin Neuropharmacol; 2009; 32(3):165-6. PubMed ID: 19483486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe vocal cord dysfunction resistant to all current therapeutic interventions.
    Goldstein R; Bright J; Jones SM; Niven RM
    Respir Med; 2007 Apr; 101(4):857-8. PubMed ID: 17029770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic ptosis with botulinum toxin in epikeratoplasty.
    Freegard T; Mackie I; Rostron C
    Br J Ophthalmol; 1993 Dec; 77(12):820-2. PubMed ID: 8110683
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.